Publications by authors named "Stephen DeWall"

Claim this Profile
N
Neutralizing Antibody Validation Testing and Reporting Harmonization.
Heather Myler, João Pedras-Vasconcelos, Todd Lester, Francesca Civoli, Weifeng Xu, Stephen DeWall

AAPS J· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity assessment of AAV-based gene therapies: An IQ consortium industry white paper.
Tong-Yuan Yang, Manuela Braun, Wibke Lembke, Fraser McBlane, John Kamerud, Stephen DeWall

Mol Ther Methods Clin Dev· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the robust humoral immune response to GSK2618960, a humanized anti-IL-7 receptor monoclonal antibody, observed in healthy subjects in a Phase 1 study.
Karen Liao, Keguan Chen, Sara Brett, Andrew Gehman, Ann M Schwartz, Stephen L DeWall

PLoS One· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward Reference Intervals of ARSA Activity in the Cerebrospinal Fluid: Implication for the Clinical Practice of Metachromatic Leukodystrophy.
Francesco Morena, Chiara Argentati, Serena Acquati, Stephen DeWall, Fiona Kelly

J Appl Lab Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity Risk Assessment for PEGylated Therapeutics.
Johanna R Mora, Joleen T White, Stephen L DeWall

AAPS J· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Study to Investigate the Efficacy and Safety of an Anti-Interleukin-18 Monoclonal Antibody in the Treatment of Type 2 Diabetes Mellitus.
Elizabeth A McKie, Juliet L Reid, Prafull C Mistry, Stephen L DeWall, Lee Abberley

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, pharmacokinetics, and pharmacodynamics of single-dose antiinterleukin- 18 mAb GSK1070806 in healthy and obese subjects.
Prafull Mistry, Juliet Reid, Isabelle Pouliquen, Simon McHugh, Lee Abberley, Stephen DeWall

Int J Clin Pharmacol Ther· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
False-positive immunogenicity responses are caused by CD20+ B cell membrane fragments in an anti-ofatumumab antibody bridging assay.
Keguan Chen, Jerry G Page, Ann M Schwartz, Thomas N Lee, Stephen L DeWall

J Immunol Methods· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a cell-based SEAP reporter assay for the detection of neutralizing antibodies against an anti-IL-13 therapeutic antibody.
Karen Liao, Dan Sikkema, Catherine Wang, Keguan Chen, Stephen DeWall

J Immunol Methods· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis